MedPath

The effect of two kinds of triggering with GnRh agonist in antagonist protocol

Phase 2
Conditions
Triggering with different doses of GnRh a in PCO patients.
Female infertility, unspecified
N97.9
Registration Number
IRCT20181211041930N1
Lead Sponsor
Yazd University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
120
Inclusion Criteria

PCOS women based on Rotterdam criteria who were candidate for ART
Serum estradiol level more than 3000 pg/ml on triggering day
Ovarian stimulation with GnRH antagonist protocol
Age between 20-38 years
Body Mass Index > 18 and < 30

Exclusion Criteria

Sever endometriosis
Sever male factor infertility
Uterine anomaly
Metabolic disease

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The number of mature oocytes (MII). Timepoint: After oocyte retrieval. Method of measurement: Counting mature oocyte under microscopy.;Number of 2PNs. Timepoint: 16 hours After fertilization. Method of measurement: Counting 2PNs under microscopy.;OHSS developing. Timepoint: Days 4 and 7 post oocyte pick-up. Method of measurement: Measuring ovarian size, presence of free fluid in Douglas.
Secondary Outcome Measures
NameTimeMethod
Embryos quality and embryo count. Timepoint: 48 hours after fertilization. Method of measurement: Assessment under microscopy by embryologist.
© Copyright 2025. All Rights Reserved by MedPath